Home
Technologies
Market Opportunity
Product Portfolio
Clinical
- Medical Meeting Calendar
Investors

Investors

Investors

Press Releases

News & Events

Corporate Governance

Management

Directors

Committees

ContactBoard

Financial Information

SEC Filings

Quarterly Results

Key Ratios

Stock Information

Historic Stock Lookup

Investment Calculator

Ownership Profile

Risk Factors

Contact Us

acura

SEC Filings

Filing date	Form	Description	View
May 15, 2023	NT 10-Q	Notification that form type 10-Q will be submitted late	0001104659-23-060535.pdf 0001104659-23-060535.xls View HTML
Aug 10, 2023	NT 10-Q	Notification that form type 10-Q will be submitted late	0001104659-23-089679.pdf 0001104659-23-089679.xls View HTML
Nov 03, 2023	NT 10-Q	Notification that form type 10-Q will be submitted late	0001104659-23-114142.pdf 0001104659-23-114142.xls View HTML
Apr 22, 1998	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0000950123-98-004037.pdf 0000950123-98-004037.xls View HTML
Apr 16, 1999	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0000950123-99-003396.pdf 0000950123-99-003396.xls View HTML
Oct 06, 2003	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0000950123-03-011140.pdf 0000950123-03-011140.xls View HTML
Oct 27, 2006	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001144204-06-043954.pdf 0001144204-06-043954.xls View HTML
May 01, 2009	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001144204-09-023580.pdf 0001144204-09-023580.xls View HTML
Jun 22, 2015	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001144204-15-038300.pdf 0001144204-15-038300.xls View HTML
May 07, 2004	PREM14A	A preliminary proxy statement relating to a merger or acquisition	0000950123-04-005940.pdf 0000950123-04-005940.xls View HTML

Data provided by Kaleidoscope.